Showing results (91-100 of 134) with videos related to

Sort By:
Pageof 14
Biochemical and Biophysical Research Communications|October 24, 2006
Recombinant amyloidogenic domain of ApoA-I: analysis of its fibrillogenic potentialSonia Di Gaetano, Fulvio Guglielmi, Angela Arciello, et al.
Protein Science : a Publication of the Protein Society|January 24, 2007
Lysine 58-cleaved beta2-microglobulin is not detectable by 2D electrophoresis in ex vivo amyloid fibrils of two patients affected by dialysis-related amyloidosisSofia Giorgetti, Monica Stoppini, Glenys A Tennent, et al.
Nanoscale|March 8, 2017
Citrate-stabilized gold nanoparticles hinder fibrillogenesis of a pathological variant of β2-microglobulinCristina Cantarutti, Sara Raimondi, Giorgia Brancolini, et al.
Molecules (Basel, Switzerland)|April 3, 2021
Clinical Amyloid Typing by Proteomics: Performance Evaluation and Data Sharing Between Two CentresDiana Canetti, Francesca Brambilla, Nigel B Rendell, et al.
FASEB Bioadvances|November 8, 2023
Human wild-type and D76N β2-microglobulin variants are significant proteotoxic and metabolic stressors for transgenic C. elegansSara Raimondi, Giulia Faravelli, Paola Nocerino, et al.
Frontiers in Molecular Biosciences|March 3, 2022
Amyloid Formation by Globular Proteins: The Need to Narrow the Gap Between in Vitro and in Vivo MechanismsGiulia Faravelli, Valentina Mondani, P Patrizia Mangione, et al.
Biophysical Journal|November 3, 2016
Biochemical and Electrophysiological Modification of Amyloid Transthyretin on CardiomyocytesLaura Sartiani, Monica Bucciantini, Valentina Spinelli, et al.
The Journal of Biological Chemistry|June 24, 2020
Comparative study of the stabilities of synthetic in vitro and natural ex vivo transthyretin amyloid fibrilsSara Raimondi, P Patrizia Mangione, Guglielmo Verona, et al.
Pageof 14